M&A Deal Summary

Tanvex Acquires Bora Biologics

On January 20, 2025, Tanvex acquired life science company Bora Biologics

Acquisition Highlights
  • This is Tanvex’s 1st transaction in the Life Science sector.
  • This is Tanvex’s 1st transaction in the United States.
  • This is Tanvex’s 1st transaction in California.

M&A Deal Summary

Date 2025-01-20
Target Bora Biologics
Sector Life Science
Buyer(s) Tanvex
Deal Type Add-on Acquisition

Target

Bora Biologics

San Diego, California, United States
Bora Biologics with a track record of over 100 successful cGMP manufacturing batches. It provides agile, comprehensive end-to-end solutions that enhance time and cost efficiencies for biopharma companies worldwide. Bora Biologics is based in San Diego, California.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Tanvex

Taipei City, Taiwan

Category Company
Founded 2011
Sector Life Science
Employees198
Revenue 35M TWD (2024)
DESCRIPTION

Tanvex has honed its expertise in biologics development and manufacturing, culminating in the successful commercialization of our first product. Tanvex was founded in 2011 and is based in Taipei City, Taiwan


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1